<DOC>
<DOCNO>
EP-0017138
</DOCNO>
<TEXT>
<DATE>
19801015
</DATE>
<IPC-CLASSIFICATIONS>
C07D-513/00 A61P-31/00 C07D-205/08 C07D-513/04 C07D-205/095 <main>C07D-513/04</main> A61K-31/54 C07D-205/00 A61K-31/397 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
analogous compounds of cephalosporins, processes for their preparation, and pharmaceutical composition containing them.
</TITLE>
<APPLICANT>
fujisawa pharmaceutical cojp<sep>fujisawa pharmaceutical co. ltd.<sep>fujisawa pharmaceutical co., ltd.3, doshomachi 4-chome higashi-kuosaka-shi osaka 541jp<sep>fujisawa pharmaceutical co., ltd.<sep>
</APPLICANT>
<INVENTOR>
aratani matsuhiko<sep>hashimoto masashi<sep>aratani, matsuhiko<sep>hashimoto, masashi<sep>aratani, matsuhikono. 4-a13-108, satakedai 1-chomesuita-shi osakajp<sep>hashimoto, masashino. 6-17, satsukidai 1-chomenakayama takarazuka-shi hyogojp<sep>aratani, matsuhiko<sep>hashimoto, masashi<sep>aratani, matsuhikono. 4-a13-108, satakedai 1-chomesuita-shi osakajp<sep>hashimoto, masashino. 6-17, satsukidai 1-chomenakayama takarazuka-shi hyogojp<sep>
</INVENTOR>
<ABSTRACT>
analogous compounds of cephalosporins of the formula    wherein r¹ is amino or a substituted amino,   r² is hydrogen or lower alkoxy, or   r¹ and r² are combined together to form a group of  the formula:    wherein r⁶ and r⁷ are each hydrogen or lower alkyl, and  a is a group of the formula:    wherein x is -s- or   --,   r³ is carboxy or a protected carboxy group and  r⁴ is hydrogon, hydroxy or acyl, and pharmaceutic­ ally acceptable salt thereof and process for their  preparation, and also a pharmaceutical composi­ tion comprising, as an effective ingredient, the  above compound in association with a pharmaceu­ tically acceptable, substantially non-toxic carrier or  excipient.  the invention also relates to the starting  compounds 
</ABSTRACT>
</TEXT>
</DOC>
